GB0021419D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0021419D0
GB0021419D0 GBGB0021419.7A GB0021419A GB0021419D0 GB 0021419 D0 GB0021419 D0 GB 0021419D0 GB 0021419 A GB0021419 A GB 0021419A GB 0021419 D0 GB0021419 D0 GB 0021419D0
Authority
GB
United Kingdom
Prior art keywords
compounds
nr3r4
co2r7
nhr7
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0021419.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Priority to GBGB0021419.7A priority Critical patent/GB0021419D0/en
Publication of GB0021419D0 publication Critical patent/GB0021419D0/en
Priority to DE60143165T priority patent/DE60143165D1/de
Priority to JP2002526865A priority patent/JP2004509121A/ja
Priority to AU2001284188A priority patent/AU2001284188A1/en
Priority to EP01963155A priority patent/EP1313731B1/en
Priority to PCT/GB2001/003860 priority patent/WO2002022612A1/en
Priority to ES01963155T priority patent/ES2353685T3/es
Priority to AT01963155T priority patent/ATE482954T1/de
Priority to US10/371,979 priority patent/US6740670B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0021419.7A 2000-08-31 2000-08-31 Compounds Ceased GB0021419D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0021419.7A GB0021419D0 (en) 2000-08-31 2000-08-31 Compounds
DE60143165T DE60143165D1 (de) 2000-08-31 2001-08-30 Thiazolidinderivate und ihre verwendung als fungizide
JP2002526865A JP2004509121A (ja) 2000-08-31 2001-08-30 チアゾリジン誘導体および抗真菌剤としてのその使用
AU2001284188A AU2001284188A1 (en) 2000-08-31 2001-08-30 Thiazolidine derivatives and its use as antifungal agent
EP01963155A EP1313731B1 (en) 2000-08-31 2001-08-30 Thiazolidine derivatives and its use as antifungal agent
PCT/GB2001/003860 WO2002022612A1 (en) 2000-08-31 2001-08-30 Thiazolidine derivatives and its use as antifungal agent
ES01963155T ES2353685T3 (es) 2000-08-31 2001-08-30 Derivados de tiazolidina y su uso como agente antifúngico.
AT01963155T ATE482954T1 (de) 2000-08-31 2001-08-30 Thiazolidinderivate und ihre verwendung als fungizide
US10/371,979 US6740670B2 (en) 2000-08-31 2003-02-21 Thiazolidine derivatives and its use as antifungal agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021419.7A GB0021419D0 (en) 2000-08-31 2000-08-31 Compounds

Publications (1)

Publication Number Publication Date
GB0021419D0 true GB0021419D0 (en) 2000-10-18

Family

ID=9898614

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0021419.7A Ceased GB0021419D0 (en) 2000-08-31 2000-08-31 Compounds

Country Status (9)

Country Link
US (1) US6740670B2 (https=)
EP (1) EP1313731B1 (https=)
JP (1) JP2004509121A (https=)
AT (1) ATE482954T1 (https=)
AU (1) AU2001284188A1 (https=)
DE (1) DE60143165D1 (https=)
ES (1) ES2353685T3 (https=)
GB (1) GB0021419D0 (https=)
WO (1) WO2002022612A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53252B (sr) 2003-08-11 2014-08-29 F.Hoffmann-La Roche Ag. Piperazin sa or-supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1
LT2653465T (lt) 2004-03-15 2016-09-12 Janssen Pharmaceutica Nv Opioidinio receptoriaus moduliatoriai
HRP20090264T1 (hr) 2004-12-09 2009-06-30 F. Hoffmann - La Roche Ag Derivati fenil-piperazin metanona
WO2006063709A1 (en) 2004-12-15 2006-06-22 F.Hoffmann-La Roche Ag Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer’s disease
US7485637B2 (en) 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
AU2005324024B2 (en) 2005-01-07 2011-02-17 F. Hoffmann-La Roche Ag [4-(Heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
AU2006207650B2 (en) 2005-01-18 2011-01-27 F. Hoffmann-La Roche Ag 2, 5-disubstituted phenyl methanone derivatives as glycine transporter 1 (GlyT-I) inhibitors for the treatment of neurological and neuropsychiatry disorders
BRPI0607241A2 (pt) 2005-01-26 2009-08-25 Hoffmann La Roche derivados de fenil metanona e o uso dos mesmos como inibidores do transportador de glicina 1
DE602006010665D1 (en) 2005-02-07 2010-01-07 Hoffmann La Roche Heterocyclsche substituierte phenylmethanone als inhibitoren des glycintransporters 1
ATE536347T1 (de) 2008-05-20 2011-12-15 Merck Sharp & Dohme Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
RU2662153C1 (ru) * 2017-04-20 2018-07-24 Общество С Ограниченной Ответственностью "Дермавитал Групп" Гибридные эфиры на основе производных тиазолидин-2,4-диона и азолов (1н-1,3-имидазола и 1н-1,3,4-триазола) и их применение
RU2690161C1 (ru) * 2018-06-28 2019-05-31 Общество С Ограниченной Ответственностью "Дермавитал Групп" 3,5-Замещенные производные тиазолидин-2,4-диона, обладающие противомикробной активностью
RU2703997C1 (ru) * 2018-12-13 2019-10-23 Общество с ограниченной ответственностью "Л-Био" Гибридные амиды на основе триазола и тиазолидина, обладающие антимикробной активностью
US11292776B2 (en) 2019-12-12 2022-04-05 University Of Sharjah Small molecule inhibitors of fungal hyphae and biofilm formation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US47109A (en) * 1865-04-04 Improvement in governors
FR1604530A (https=) * 1967-06-06 1971-11-29
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
DE4318550A1 (de) * 1993-06-04 1994-12-08 Boehringer Mannheim Gmbh Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19835316A1 (de) * 1998-08-05 2000-02-10 Bosch Gmbh Robert Gesteuerte Gleichrichterbrücke mit Überspannungsschutz
EP1117655A1 (en) * 1998-09-30 2001-07-25 Angelika Esswein Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders

Also Published As

Publication number Publication date
WO2002022612A1 (en) 2002-03-21
AU2001284188A1 (en) 2002-03-26
JP2004509121A (ja) 2004-03-25
DE60143165D1 (de) 2010-11-11
US20030216453A1 (en) 2003-11-20
EP1313731B1 (en) 2010-09-29
ES2353685T3 (es) 2011-03-04
EP1313731A1 (en) 2003-05-28
ATE482954T1 (de) 2010-10-15
US6740670B2 (en) 2004-05-25
WO2002022612A8 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
GB0021419D0 (en) Compounds
BR0208365A (pt) Derivados de 2-amino-propanol
DE60141706D1 (de) Verbindungen mit fungizider wirkung und verfahren zur ihrer herstellung und verwendung
SE9103572D0 (sv) Organic salts of n,n'-diacetyl cystine
EA200300348A1 (ru) Спирогетероциклические нитрилы, пригодные для применения в качестве обратимо действующих ингибиторов цистеиновых протеаз
FI955315A0 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
AR037695A1 (es) Composicion para el tratamiento del cabello
NO20054412L (no) Antineoplastiske kombinasjoner
AU2001284190A1 (en) Benzylidene thiazolidinediones and their use as antimycotic agents
BR0103736A (pt) Uso de uma composição que compreende pelo menos um composto metalo-orgânico e processo de tratamento das matérias queratìnicas
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
JP2002179603A5 (https=)
PT96664A (pt) Processo para a preparacao de derivados neuroprotectores de 3-piperidino-4-hidroxicromano
IL155263A0 (en) Pharmaceutical solutions of modafinil compounds
FI920430A0 (fi) Benzyloxifenylderivator.
ATE162181T1 (de) Phenylalkan(en)-säuren mit leukotriene b4 antagonistischer wirkung
ATE333901T1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
SE9904674D0 (sv) Novel compounds
DE69903053D1 (de) Diaminocyclobuten-3,4-dionderivate, deren herstellung und deren verwendung
WO2003010382A1 (en) Fiber structure having high whiteness and high moisture-absorbing and releasing property, and method for production thereof
ATE250610T1 (de) Kaliumkanal-blockierende mittel
EA200101001A1 (ru) Декурсинол или его производное в качестве аналгезирующего средства
BR0009453B1 (pt) processo para a preparação de um composto.
DE60130615D1 (de) Verfahren zur Herstellung von 6-Alpha-Fluoro,9,11-Beta-Epoxy-Steroide
UY26416A1 (es) Compuestos

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)